- Centers for Disease Control and Prevention. Guidelines for preventing the transmission of
Mycobacterium tuberculosisin health-care facilities. MMWR Morb Mortal Wkly Rep 1994; 43:1–132. - McKinnon HD Jr., Howard T. Evaluating the febrile patient with a rash. Am Fam Physician 2000;
62(4):804–816. - Nesbitt LTJ. Evaluating the patient with a skin infection: general considerations. In: Sanders CV,
Nesbitt LTJ, eds. The Skin and Infection: A Color Atlas and Text. Baltimore: Williams and Wilkins,
1995:1–6. - Schuchat A, Robinson K, Wenger JD, et al. Bacterial meningitis in the United States in 1995. Active
Surveillance Team. N Engl J Med 1997; 337(14):970–976. - Yung AP, McDonald MI. Early clinical clues to meningococcaemia. Med J Aust 2003; 178(3):134–137.
- van Deuren M, Brandtzaeg P, van der Meer JW. Update on meningococcal disease with emphasis on
pathogenesis and clinical management. Clin Microbiol Rev 2000; 13(1):144–166. - Pollard AJ, Britto J, Nadel S, et al. Emergency management of meningococcal disease. Arch Dis Child
1999; 80(3):290–296. - Mclean S, Caffey J. Endemic purpuric meningococcus bacteremia in early life: the diagnostic value of
smears from purpuric lesions. Am J Dis Child 1931; 42:1053–1074. - Hill WR, Kinney TD. The cutaneous lesions in acute meningococcemia: a clinical and pathological
study. JAMA 1947; 134:513–518. - Faust SN, Levin M, Harrison OB, et al. Dysfunction of endothelial protein C activation in severe
meningococcal sepsis. N Engl J Med 2001; 345(6):408–416. - Bernhard WG, Jordan AC. Purpuric lesions in meningococcal infections: diagnosis from smears and
cultures of the purpuric lesions. J Lab Clin Med 1944; 29:273–281. - van Deuren M, van Dijke BJ, Koopman RJ, et al. Rapid diagnosis of acute meningococcal infections
by needle aspiration or biopsy of skin lesions. BMJ 1993; 306(6887):1229–1232. - Gregory B, Tron V, Ho VC. Cyclic fever and rash in a 66-year-old woman. Chronic meningococcemia.
Arch Dermatol 1992; 128(12):1645–1648. - Ploysangam T, Sheth AP. Chronic meningococcemia in childhood: case report and review of the
literature. Pediatr Dermatol 1996; 13(6):483–487. - Permetier L, Garzoni C, Antille C, et al. Value of a novelNeisseria meningitidis-specific polymerase
chain reaction assay in skin biopsy specimens as a diagnostic tool in chronic meningococcemia. Arch
Dermatol 2008; 144(6):770–773. - Masters EJ, Olson GS, Weiner SJ, et al. Rocky Mountain spotted fever: a clinician’s dilemma. Arch
Intern Med 2003; 163(7):769–774. - Sexton DJ, Kaye KS. Rocky mountain spotted fever. Med Clin North Am 2002; 86(2):351–360.
- Thorner AR, Walker DH, Petri WA Jr. Rocky mountain spotted fever. Clin Infect Dis 1998; 27(6):
1353–1359. - Jacobs RF. Human monocytic ehrlichiosis: similar to Rocky Mountain spotted fever but different.
Ped Annals 2002; 31(3):180–184. - Rocky Mountain Spotted Fever, CD, , 2008, Available at: http://www.cdc.gov/ncidod/dvrd/rmsf/
Epidemiology.htm. - Parola P, Socoloschi C, Jeanjena L, et al. Warmer weather linked to tick attack and emergence of
severe rickettsioses. PLoS Negl Trop Dis 2008; 2(11):e338(1–8). - Cunha BA. Clinical features of Rocky Mountain spotted fever. Lancet Infect Dis 2008; 8(3):143–144.
- Holman RC, Paddock CD, Curns AT, et al. Analysis of risk factors for fatal Rocky Mountain Spotted
Fever: evidence for superiority of tetracyclines for therapy. J Infect Dis 2001; 184(11):1437–1444. - Kirkland KB, Marcom PK, Sexton DJ, et al. Rocky Mountain spotted fever complicated by gangrene:
report of six cases and review. Clin Infect Dis 1993; 16(5):629–634. - Chen LF, Sexton DJ. What’s new in Rocky Mountain spotted fever? Infect Dis Clin North Am 2008;
22(3):415–432. - Raoult D, Parola P. Rocky Mountain spotted fever in the USA: a benign disease or a common
diagnostic error. Lancet Infect Dis 2008; 8(10):587–589. - Dantas-Torres F. Rocky Mountain spotted fever. Lancet Infect Dis 2007; 7(11):724–732.
- Rangel-Frausto MS. The epidemiology of bacterial sepsis. Infect Dis Clin North Am 1999; 13(2):299–312.
- Annane D, Bellissant E, Cavaillon JM. Septic shock. Lancet 2005; 365(9453):63–78.
- Alberti C, Brun-Buisson C, Goodman SV, et al. Influence of systemic inflammatory response
syndrome and sepsis on outcome of critically ill infected patients. Am J Respir Crit Care Med 2003;
168(1):77–84. - Dombrovskiy YY, Martin AA, Sunderram J, et al. Rapid increase in hospitalization and mortality
rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med 2007;
35(5):1244–1250.
42 Engel et al.